Latest News
Sector movers: China and US growth concerns weigh on commodity plays
Stocks in the UK ended the session clearly in the red amid growth concerns in China and the US, which resulted in broad-based losses in the commodities space.
US close: Stocks sharply lower following August manufacturing PMIs
Wall Street stocks closed firmly lower on Tuesday as traders returned from the Labor Day long weekend to fresh manufacturing data.
Wednesday preview: Services PMIs, Direct Line Group in focus
The market spotlight in the middle of the week will be on the health of the services sector on either side of the Channel.
Broker tips: Hikma Pharmaceuticals, Judges Scientific, Michelmersh Brick
Berenberg upgraded Hikma Pharmaceuticals on Tuesday and lifted the price target to 2,400. 0p from 2,100. 0p as it said "clear progress" had been made.
London close: Stocks slip as investors digest UK, US data
London stocks ended Tuesday in negative territory as investors reacted to the latest UK retail sales date, and a fresh manufacturing sector reading out of the US.
Director dealings: Gateley director snaps up shares
Gateley revealed on Tuesday that non-executive director Edward Knapp had acquired 16,254 ordinary shares in the AIM-listed professional services firm.
ISM factory PMI edges up by less than expected in August
Factory sector activity in the States shrank at a slightly lower pace in August, the results of a closely followed survey showed.
FTSE 250 movers: WOSG surges on results; Wizz flies lower
London’s FTSE 250 was down 0. 9% at 20,791. 37 in afternoon trade on Tuesday.
Europe midday: Stocks dip into the red ahead of US data
European stocks had dipped into the red by midday on Tuesday as investors eyed a raft of US data later in the day and the week.
US open: Stocks sharply lower following manufacturing PMIs
Wall Street stocks were firmly in the red early on Tuesday as traders returned from the Labor Day long weekend to fresh manufacturing data.
FTSE 100 movers: Ashtead rallies; Rightmove gives back some gains
London’s FTSE 100 was down 0. 8% at 8,296. 96 in afternoon trade on Tuesday.
Oriole reports encouraging results from Mbe gold project
West and central Africa-focussed gold explorer Oriole Resources announced encouraging initial results from its Mbe gold project in the Adamawa region of Cameroon on Tuesday.
Canaccord Genuity lowers target price on Michelmersh Brick Holdings
Analysts at Canaccord Genuity lowered their target price on building products manufacturer Michelmersh Brick Holdings from 180. 0p to 170. 0p on Tuesday following the group's interim trading results.
Bradda Head identifies significant targets at San Domingo
North America-focussed lithium developer Bradda Head announced the identification of significant drill targets at its San Domingo pegmatite project in central Arizona on Tuesday.
Aptamer extends contract with Unilever
Custom antibody alternatives business Aptamer said on Tuesday that it has extended its contract with household goods giant Unilever to progress its Optimer asset for deodorant development.
US pre-open: Stocks seen lower ahead of key data releases
US futures pointed to a weaker open on Wall Street on Tuesday as investors eyed key manufacturing data releases, as well as jobs data later in the week.
London midday: Stocks turn negative ahead of US data
London stocks had moved into the red by midday on Tuesday as investors mulled the latest UK retail sales figures and looked ahead to key US data releases.
Mkango subsidiary Maginito inks exclusive deal with Inserma Anoia
Mkango Resources and its subsidiary Maginito announced a significant exclusive agreement with Inserma Anoia on Tuesday, to commercialise and optimise pre-processing technologies for rare earth magnet recovery from hard disk drives (HDDs), loudspeakers, and electric motors.
Duke Capital invests another £3m in United Glass Group
Duke Capital announced a follow-on investment of £3m in its existing capital partner United Glass Group (UGG) on Tuesday.
Jefferies starts Judges Scientific at ‘buy’ after share price correction
Jefferies initiated coverage on Judges Scientific on Tuesday with a ‘buy’ rating and 12,230p price target, as it said the valuation is more attractive following the recent share price correction, particularly if potential M&A upside is considered.